| Literature DB >> 36076882 |
Francesca Anna Ramires1, Stefania De Domenico1,2, Danilo Migoni2, Francesco Paolo Fanizzi2, Dror L Angel3, Rasa Slizyte4, Katja Klun5, Gianluca Bleve1, Antonella Leone1,6.
Abstract
Edible jellyfish are a traditional Southeast Asian food, usually prepared as a rehydrated product using a salt and alum mixture, whereas they are uncommon in Western Countries and considered as a novel food in Europe. Here, a recently developed, new approach for jellyfish processing and stabilization with calcium salt brining was upgraded by modifying the pre-treatment step of freshly caught jellyfish and successfully applied to several edible species. Treated jellyfish obtained by the application of the optimized version of this method respected both quality and safety parameters set by EU law, including no pathogenic microorganisms, absence or negligible levels of histamine and of total volatile basic nitrogen, no heavy metals; and the total bacterial, yeast, and mold counts were either negligible or undetectable. Jellyfish treated by the presented method exhibited unique protein content, amino acid and fatty acid profiles, antioxidant activity, and texture. The optimized method, initially set up on Rhiszostoma pulmo, was also successfully applied to other edible jellyfish species (such as Cotylorhiza tuberculata, Phyllorhiza punctata, and Rhopilema nomadica) present in the Mediterranean Sea. This study discloses an innovative process for the preparation of jellyfish-based food products for potential future distribution in Europe.Entities:
Keywords: jellyfish; novel food; nutritional traits; organic calcium salts; quality; safety
Year: 2022 PMID: 36076882 PMCID: PMC9455609 DOI: 10.3390/foods11172697
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Diagram illustrating the procedure of the JF treatment procedures.
Safety and quality parameters applied to JF-B (JF directly pre-treated on the boat) and JF-DW (JF washed with drinking water). Samples were treated for 5 days with calcium citrate (Ca-Citrate) or calcium lactate (Ca-Lactate) brines, following accredited conventional assays used for seafood and fish-derived products (as already described by Bleve et al. [15]). The different letters in line indicate significant differences between samples (p < 0.05).
| Accredited Analysis | Ca-Citrate | Ca-Lactate | ||
|---|---|---|---|---|
| JF-B | JF-DW | JF-B | JF-DW | |
| CFU/g | CFU/g | CFU/g | CFU/g | |
|
| <10 (a) | 1.30 × 103 ± 1.23 × 101 (b) | <10 (a) | 3.70 × 102 ± 2.31 (c) |
|
| <10 (a) | <10 (a) | <10 (a) | <10 (a) |
|
| <10 (a) | <10 (a) | <10 (a) | <10 (a) |
|
| 1.60 × 102 ± 5.21 (a) | 1.00 x 102 ± 7.25 (a) | 1.00 × 102 ± 8.32 (a) | 7.30 × 101 ± 6.15 (a) |
|
| <10 (a) | <10(a) | <10 (a) | <10 (a) |
|
|
|
|
| |
|
| 0 (a) | 0 (a) | 0 (a) | 0 (a) |
|
| 0 (a) | 0 (a) | 0 (a) | 0 (a) |
|
|
|
|
| |
|
| <3 (a) | <3 (a) | <3 (a) | <3 (a) |
|
|
|
|
| |
|
| <0.1 (a) | <0.1 (a) | 2.5 ± 0.1 (b) | <0.1 (a) |
Texture, pH, and salinity values of R. pulmo JF-B (JF directly pre-treated on the boat) and JF-DW (JF washed with drinking water). JF samples were untreated and treated with brines containing different calcium salts at 5 days of treatment (Ca-Citrate: calcium citrate; Ca-Lactate: calcium lactate), and JF-DW was treated with salt–alum (obtained after 20 days at 4 °C and 2 days of air drying, as described in the Material and Methods section).
| Pre-Treatments | Treatments | |||
|---|---|---|---|---|
| Untreated | Ca-Citrate | Ca-Lactate | Salt-Alum | |
|
| ||||
|
| −74 ± 15 (a) | −34 ± 11 (b) | −53 ± 8 (b) | n.d. |
|
| −75 ± 10 (a) | −137 ± 15 (b) | −117 ± 5 (b) | −43 ± 11(c) |
|
| ||||
|
| 3.5 ± 0.1 (a) | 2 ± 0.2 (b) | 2.4 ± 0.1 (b) | n.d. |
|
| 3.5 ± 0.2 (a) | 1.5 ± 0.3 (b) | 1.8 ± 0.2 (b) | 2.5 ± 0.1 (c) |
|
| ||||
|
| 7.1 ± 0.2 (a) | 4.72 ± 0.2 (b) | 7.06 ± 0.3 (a) | n.d. |
|
| 6.9 ± 0.3 (a) | 5.2 ± 0.1 (b) | 5.56 ± 0.4 (b) | 3.65 ± 0.4 (c) |
The different letters in line indicate significant differences between the samples (p < 0.05). N: Newton; n.d., not determined.
Figure 2(a) Protein content expressed in mg per 100 g of fresh weight (mg/100 g FW) and (b) antioxidant activity expressed in nmol TE per gram of fresh weight (nmol TE/g FW) in differently treated samples of R. pulmo jellyfish. JF-DW, R. pulmo washed with drinking water; Ca-Lactate JF-DW and Ca-Citrate JF-DW, JF samples treated with calcium lactate or calcium citrate brines for 5 days, respectively; Salt-Alum JF-DW, samples of R. pulmo JF-DW treated with salt and alum following the traditional method; Salt-alum Jp, commercial ready-to-eat sample of JF produced in Japan by a traditional alum-based method. Values are the means of three independent measurements ± standard deviation. ANOVA statistical test followed by Dunnett’s multiple comparison post hoc test were used to compare each treatment with the control (* p < 0.05 and *** p < 0.001).
Fatty acid composition of R. pulmo JF samples. They were washed with drinking water (JF-DW), treated with brines containing calcium salts (Ca-Citrate JF-DW and Ca-Lactate JF-DW), or treated with the salt–alum method (Salt-Alum JF-DW); a commercial JF sample from Japan treated by the salt–alum method (Salt-Alum Jp) was also tested. Fatty acid composition data are expressed as the percentage of the total fatty acids ± SD.
| Fatty Acids Composition (%) | |||||
|---|---|---|---|---|---|
| Commercial JF | |||||
| JF-DW | Ca-Citrate JF-DW | Ca-Lactate JF-DW | Salt-Alum JF-DW | Salt-Alum Jp | |
|
| |||||
|
| 4.0 ± 0.4 | 7.5 ± 0.8 | 7.2 ± 0.7 | 4.1 ± 0.4 | 2.6 ± 0.3 |
|
| –– | –– | –– | 1.7 ± 0.2 | –– |
|
| 23.5 ± 2.5 | 34.9 ± 4.3 | 28.4 ± 0.3 | 35.4 ± 3.5 | 31.5 ± 3.1 |
|
| 1.1 ± 0.2 | 1.3 ± 0.3 | 3.6 ± 0.1 | 4.8 ± 0.5 | 2.5 ± 0.3 |
|
| 21.8 ± 2.1 | 35.6 ± 4.2 | 22.4 ± 2.3 | 32.9 ± 3.3 | 47.2 ± 4.8 |
|
| –– | –– | 2.8 ± 0.3 | 0.7 ± 0.1 | 0.6 ± 0.1 |
|
| –– | –– | –– | 1.1 ± 0.1 | 1.5 ± 0.1 |
|
| –– | –– | –– | 0.3 ± 0.1 | 0.7 ± 0.1 |
|
| –– | –– | –– | 0.3 ± 0.1 | 0.6 ± 0.1 |
|
| 50.4 ± 5.1 | 79.3 ± 0.8 | 64.4 ± 6.5 | 81.3 ± 8.2 | 87.1 ± 8.7 |
|
| |||||
|
| –– | 2.7± 0.3 | 4.5± 0.5 | 3.5 ± 0.4 | 2.9 ± 0.3 |
|
| 2.5 ± 2.1 | 2.0 ± 0.2 | 3.1 ± 0.3 | 1.4 ± 0.1 | –– |
|
| 1.8 ± 0.2 | –– | 2.0 ± 0.2 | –– | 1.3 ± 0.1 |
|
| –– | 1.1 ± 0.1 | –– | 5.3 ± 0.5 | 3.8 ± 0.4 |
|
| –– | –– | –– | 2.8 ± 0.3 | –– |
|
| –– | –– | –– | 0.5 ± 0.1 | –– |
|
| 4.3 ± 0.5 | 5.8 ± 0.6 | 9.6 ± 0.1 | 13.9 ± 1.4 | 8.0 ± 0.8 |
|
| |||||
|
| –– | –– | 3.1 ± 0.5 | 2.0 ± 0.2 | 3.9 ± 0.4 |
|
| –– | 3.9 ± 0.4 | –– | –– | –– |
|
| –– | –– | 2.0 ± 0.2 | –– | –– |
|
| –– | –– | 2.8 ± 0.3 | –– | –– |
|
| –– | –– | –– | –– | –– |
|
| 33.8 ± 3.4 | 3.6 ± 0.4 | 4.5 ± 0.1 | 2.0 ± 0.2 | 1.0 ± 0.1 |
|
| 5.4 ± 0.4 | 4.0 ± 0.4 | 6.3 ± 0.6 | 0.4 ± 0.1 | –– |
|
| 2.1 ± 0.2 | –– | 1.0 ± 0.1 | –– | –– |
|
| 4.1 ± 0.4 | 3.4 ± 0.3 | 6.3 ± 0.6 | 0.4 ± 0.1 | –– |
|
| 45.4 ± 4.5 | 14.9 ± 1.5 | 26.0 ± 1.9 | 4.8 ± 0.5 | 4.9 ± 0.5 |
|
| 33.8 ± 3.4 | 3.6 ± 0.4 | 7.6 ± 0.6 | 4.0 ± 0.4 | 4.9 ± 0.5 |
|
| 11.6 ± 1.0 | 7.4 ± 0.7 | 18.4 ± 1.8 | 0.9 ± 0.2 | –– |
|
| 2.9 | 0.5 | 0.4 | 4.6 | 4.9 |
|
| 8.3 ± 0.9 | 13.2 ± 1.2 | 12.5 ± 1.3 | 6.3 ± 0.5 | 3.6 ± 0.4 |
Elements evaluated in the samples of R. pulmo subjected to different treatments. JF-DW, JF samples washed with drinking water; Ca-Citrate JF-DW and Ca-Lactate JF-DW, R. pulmo JF treated with brines containing calcium citrate or calcium lactate, respectively; Salt-Alum JF-DW, JF samples treated with an alum-based procedure; Salt-Alum Jp, commercial JF treated with alum from Japan. Data are expressed in ppm ± SD; the different letters in line indicate significant differences between samples (p < 0.05).
|
| Commercial | |||
|---|---|---|---|---|
| Elements | Ca-Citrate JF-DW | Ca-Lactate JF-DW | Salt-Alum JF-DW | Salt-Alum Jp |
| Ppm | ||||
|
| 0 (a) | 0 (a) | 8.554 ± 0.432 (b) | 9.844 ± 0.432 (c) |
|
| 0.05722 ± 0.00411 (a) | 0.20558 ± 0.04742 (a) | 5213.552 ± 157.573 (b) | 5979.045 ± 104.524 (c) |
|
| 0.02667 ± 0.00103 (a) | 0.03526 ± 0.00016 (a) | 0.202 ± 0.002 (b) | 0.236 ± 0.019 (c) |
|
| 0.71483 ± 0.13397 (a) | 0.71211 ± 0.16684 (a) | 33.981 ± 0.255 (b) | 84.628 ± 0.838 (c) |
|
| 0.02983 ± 0.00486 (a) | 0.02834 ± 0.00413 (a) | 44.510 ± 0.289 (b) | 8.693± 0.350 (c) |
|
| 0 | 0 | 0 | 0 |
|
| 1480.38 ± 51.1962 (b) | 736.053 ± 16.5789 (a) | 632.589± 0.178 (c) | 141.498 ± 0.090 (d) |
|
| 0.0016 ± 0.00036 (a) | 0.00163 ± 0.00021 (a) | 0 (b) | 0 (b) |
|
| 0.00055 ± 0.00008 (b) | 0.00071 ± 0.00008 (a) | 0 (c) | 0 (c) |
|
| 0.00072 ± 0.00005 (a) | 0.00226 ±0.00009 (a) | 87.544 ± 0.187 (b) | 11.906 ± 0.131 (c) |
|
| 0.02392 ± 0.00483 (a) | 0.02484 ± 0.00563 (a) | 8.180 ± 0.037 (b) | 8.578 ± 0.124 (c) |
|
| 0.09768 ± 0.04256 (a) | 0.18979 ± 0.01947 (a) | 284.792 ± 8.383 (b) | 10.189 ± 1.345 (c) |
|
| 0 (b) | 0.01079 ± 0.00789 (a) | 0 (b) | 0 (b) |
|
| 0 | 0 | 0 | 0 |
|
| 116.364 ± 29.4737 (a) | 121.895 ± 40.5789 (a) | 12021.737± 135.355 (b) | 1241.373 ± 18.463(c) |
|
| 0.02682 ± 0.00457 (a) | 0.02668 ± 0.00526 (a) | 1.145 ± 0.008 (b) | 0.536 ± 0.018 (c) |
|
| 642.584 ± 91.866 (a) | 545.632 ± 156.474 (a) | 1664.770 ± 62.521 (b) | 352.398 ± 9.879 (a,d) |
|
| 0.00653 ± 0.00022 (a) | 0.02137 ± 0.00153 (a) | 140.681 ± 0.071 (b) | 3.532 ± 0.203 (c) |
|
| 0.0028 ± 0.00008 (a) | 0.00339 ± 0.00008 (a) | 2.084 ± 0.100 (b) | 5.286 ± 0.551 (c) |
|
| 3858.61 ± 715.55 (a) | 3165.26 ± 1127.89 (a) | >10000 (b) | >10000 (b) |
|
| 0.00069 ± 0.00017 (b) | 0.00147 ± 0.00011 (a) | 0 (c) | 0 (c) |
|
| 0 (a) | 0 (a) | 9.748 ± 0.372 (b) | 0 (a) |
|
| 2.88278 ± 0.47129 (a) | 2.77105 ± 0.48684 (a) | 25.813 ± 9.1158 (b) | 5.960 ± 0.157 (a,b) |
|
| 0.00012 ± 0.0002 (b) | 0.00103 ± 0.0005 (a) | 0 (b,c) | 0 (b,c) |
|
| 0 | 0 | 0 | 0 |
|
| 0.47493 ± 0.08632 (a) | 0.46234 ± 0.10503 (a) | 12.180 ± 0.034 (b) | 81.073 ± 0.002 (b) |
|
| 0.34144 ± 0.03876 (a) | 0.47313 ± 0.02434 (a) | 36.019 ± 0.221 (b) | 2.606 ± 0.033 (b) |
Figure 3PCA of parameters associated with all treated JF samples. The PCA variables were the data obtained from the analysis of the values of physical traits and the concentrations of chemical compounds at the end of the process. The figure displays the sample scores and variable loadings in the planes formed by PC1–PC2.